ConductScience.org, home

Trial · NCT02483624

3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus

NCT02483624, Phase 1, Terminated, Northwell Health

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. 3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus. Trials, record NCT02483624. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02483624

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus
NCT number
NCT02483624
Status
Terminated
Phases
Phase 1
Enrollment
6 participants, actual
Lead sponsor
Northwell Health
Conditions
SLE
Interventions
BR-DIM, Placebo
First posted
2015-06-29
Last updated
2016-02-01

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimarySafety and Tolerability Routine clinical and laboratory parameters as well as SLE activity measurement with SELENA Systemic Lupus Erythematosus Disease Activity Index assessment.14 monthsRoutine clinical and laboratory parameters as well as SLE activity measurement with SELENA Systemic Lupus Erythematosus Disease Activity Index assessment.
PrimaryEstradiol Hydroxylation Pathways14 monthsMeasure alterations in the ratio of 2-hydroxyestrone/ 16alpha-hydroxyestrone (2-OHE/16alpha-OHE) in the urine.
PrimaryAutoantibody Production14 MonthsRoutine lab testing to determine whether DIM supplementation will decrease autoantibody production
PrimaryT and B Lymphocytes14 Months
Qualitative and quantitative abnormalities in B- and T-lymphocytes abound in human SLE. In this aim, phenotypic analyses of B- and T-lymphocyte subsets as well as functional analyses will be ascertained in order to evaluate the effects of DIM on these parameters.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers17

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
308087BACKGROUNDPubMed
508370BACKGROUNDPubMed
1394437BACKGROUNDPubMed
1656396BACKGROUNDPubMed
1893517BACKGROUNDPubMed
3186693BACKGROUNDPubMed
3890479BACKGROUNDPubMed
7240374BACKGROUNDPubMed
8943806BACKGROUNDPubMed
9168187BACKGROUNDPubMed

1 to 10 of 17

See all 17 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02483624

GET https://conductscience.org/api/trials/v1/NCT02483624/registered